OQS
CORT icon

Occudo Quantitative Strategies’s Corcept Therapeutics CORT Stock Holding History

Occudo Quantitative Strategies’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,600
Closed -$282K – 690
2024
Q4 		$282K Buy
+5,600
New +$293K 0.05% 472
2024
Q1 		– Sell
-36,510
Closed -$1.19M – 781
2023
Q4 		$1.19M Buy
+36,510
New +$1M 0.16% 173
2022
Q4 		– Sell
-37,685
Closed -$966K – 1037
2022
Q3 		$966K Buy
+37,685
New +$1.01M 0.08% 409

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Occudo Quantitative Strategies's CORT Position: Q1 2025 in Review

Occudo Quantitative Strategies sold out of Corcept Therapeutics (CORT) in Q1 2025, closing a stake of 5,600 shares — an estimated $282K sold.

Occudo Quantitative Strategies first reported a position in CORT in Q3 2022 and held it in 3 quarters. The position peaked at $1.19M in Q4 2023. 422 funds tracked by Wall St. Rank hold CORT as of Q1 2025.

  • Occudo Quantitative Strategies reported no remaining Corcept Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,600 Corcept Therapeutics shares in Q1 2025, an estimated $282K.
  • Occudo Quantitative Strategies first reported a position in Corcept Therapeutics in Q3 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Corcept Therapeutics position peaked at $1.19M in Q4 2023.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2025, filed 15 May 2025.